Light-Induced Fluorescence Techniques for Gastrointestinal Tumour Detection by Ekaterina Borisova et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
14 
Light-Induced Fluorescence Techniques  
for Gastrointestinal Tumour Detection 
Ekaterina Borisova1, Borislav Vladimirov2, 
Radina Ivanova3 and Latchezar Avramov1 
1Institute of Electronics, Bulgarian Academy of Sciences, 
2Department of Gastroenterology, University hospital “Queen Yoanna-ISUL”, 
3Laboratory of pathomorphology, University hospital of Endocrinology,  
Medical University, Sofia,  
Bulgaria 
1. Introduction  
Gastrointestinal tumors have major place in the statistics of newly developed cancers every 
year, as the colon cancer is on third place, stomach cancer is on fifth place, and esophageal 
cancer is also in the top ten of tumors according statistics of cancer incidence. Usually the 
tumors are detected on advanced III and IV stage, where the perspectives for the patients 
are not very optimistic (Danon, 2003; Jemal, 2011). Up to now white light endoscopy is the 
main method in detection of gastrointestinal tumors. White-light endoscopy is well-
established and wide used modality. However, despite the many technological advances 
that have been occurred, conventional white light endoscopy is suboptimal and usually 
detects lesions, which already have symptoms of obstruction, bleeding and pain, related to 
tumor growth. Misdiagnoses, related to difficulties in differentiation of inflammatory from 
initial stage adenocarcinoma also have negative effect on the diagnostic accuracy (Da Costa, 
2003). Only experienced gastroenterologists with long practice in endoscopy observations 
could find slight initial changes to dysplastic and neoplastic stages of esophageal, stomach 
or colon mucosa. 
The limitations of standard endoscopy for detection and evaluation of cancerous changes 
in gastrointestinal tract are significant challenge and initiate development of new 
diagnostic modalities. Such detection and visualization techniques, additional to standard 
endoscopy equipment, including optical detection of tissues alterations are investigated 
and their feasibilities for clinical usage are evaluated. Advances in fiber optics, light 
sources, detectors have led to the development of several novel methods for tissue 
evaluation in situ. Optical methods applied for such tissue evaluation often are referred 
under term “optical biopsy”, which indicate their possibilities to make an instant 
diagnosis at endoscopy, previously possible only by using of histological and/or 
cytological analysis (Wang, 2004). 
The new optical approaches are based on light-tissue interactions and differences 
occurred between normal and abnormal tissue sites.  In gastroenterology several optical 
methods are applied recently, such as optical coherent tomography (Tumlinson, 2004), 
chromo-endoscopy, confocal fluorescent microscopy (DaCosta, 2003a; 2003b), Raman 
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spectroscopy (Yan, 2005), reflectance spectroscopy (Sun, 2001) and laser- and light-
induced fluorescence spectroscopy (Chissov, 2003). In general, photodiagnostic 
techniques may be very useful for the detection of pre-maliganant dysplasia and early 
malignant changes in gastrointestinal tract. Spectral diagnosis can provide both imaging 
and spectroscopic information; and the techniques divide into those that provide 
morphological data and those that have the potential for molecular and biochemical 
information. Morphological information provides in vivo histology and the techniques 
include optical coherence tomography, light scattering spectroscopy, and confocal 
microscopy. Fluorescence imaging and spectroscopy provide both morphological and 
biochemical data. Raman spectroscopy provides the most powerful tool for obtaining 
precise molecular data. 
Such advanced methods go beyond standard endoscopic techniques and allow receiving 
better image resolution, contrast, higher sensitivity, tissue penetration and could provide 
even biochemical, structural and molecular information about mucosal lesions investigated. 
One of the most sensitive optical detection approaches is light-induced fluorescence 
spectroscopy (LIFS) of gastrointestinal mucosa for neoplasia detection. This technique is 
most widely examined from among of spectroscopic techniques in general, because of its 
rapid and highly sensitive response to early biochemical and morphological changes in the 
tissues.  
Fluorescent diagnosis of tumor tissues becomes a valuable tool in the clinical practice. This 
technique could be applied for detection and evaluation of tumors in different localizations 
using endoscopic equipment. Such combined white-light and fluorescent mode endoscopic 
systems are already developed and introduced in the clinic for the needs of bronchoscopy 
and lung cancer diagnosis, like D-Light system of Karl Storz GmbH,  DAFE system 
(Diagnostic AutoFluorescence Endoscope) of Richard Wolf GmbH, LIFE (Lung Fluorescence 
Endoscopy System) of Xillix Technologies Corp. (DaCosta, 2003; Gabreht, 2007; McMicheal, 
1997; Chissov, 2003). 
However, fluorescent gastroscopes are still on its research and development phases and 
from the best we know the few existing systems, such as Olimpus Evis Lucera, has not 
received yet all approvals for access to the broad clinical market. This system is a 
digestive tract videoscope used for observing of blood vessels in mucous membranes 
under infrared light in the regions 790-820 nm and 905-970 nm. Variation of Xillix 
fluorescent endoscopic system – Xillix-LIFE-GI is applied for autofluorescence detection 
of stomach neoplasia and has approval for Japan and European countries. Several 
fluorescent endoscopy systems are developed and proposed also for applications in the 
practice by different research teams, demonstrating very good clinical results (Chissov, 
2003; Papayan, 2006; Sokolov, 2002), using autofluorescence or exogenous fluorescence 
detection of gastrointestinal neoplasia. 
Despite of the fluorescent endoscopic systems developed mentioned above, the 
fluorescent diagnosis of tumors of the upper part of gastrointestinal tract still is very 
interesting and extensive research and development task worldwide. On the current 
moment detecting the difference in autofluorescence as a gastroendoscopic image still has 
been relatively difficult task because of its faintness. Recent real time gastrointestinal 
fluorescence endoscopy is all based on the use of exogenous fluorophores (DaCosta, 2003; 
Sokolov, 2002; Prost, 2002), that increase the contrast, improve endoscopic resolution  
and sampling, and could be used to receive better 2-D visualization for the needs of 
clinicians. 
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We prepare a general review of the recent techniques, experimental achievements and 
general approaches applied in the field of light-induced fluorescence endoscopy of the 
gastrointestinal tract, as well as will provide below examples from our own research in 
this area. Broad literature survey is carried out to allow precise and extensive comments 
on advantages, drawbacks and future steps needed to be developed in this investigation 
area. 
Advances in spectroscopic instruments will improve imaging’s role as a facilitator of 
research translation. Results received in our studies could serve for development of tools for 
quantifying in vivo tumor growth and origin and for accelerating the transition from pre-
clinical studies to early clinical trials and to routine diagnostic practice. 
2. Principles and methods 
Light-induced fluorescence spectroscopy of biological tissues is based on the physical 
phenomenon that when with a light beam in appropriate spectral region one irradiates some 
biological sample it could re-emit the light with a spectrum, related to its biochemical 
content. These molecules, which are in the tissue and re-emit the light, are called 
fluorophores, and the process itself is called fluorescence. Light sources that can be used 
include incoherent light sources such as Xe or Hg lamps, light-emitting diodes or 
monochromatic laser light. When light penetrate into the tissue, it could cause reflection 
from the tissue layers and non-homogeneities in the tissue; could cause absorption, as well 
as fluorescence. If only endogenous fluorophores, naturally existing in the sample, are used 
to obtain fluorescent signal from the tissue one could observe autofluorescence. If 
fluorescent compound is added (e.g. injected) into the tissue exogenous fluorescence is 
observed (Ell, 2003; Song, 2003, Song, 2005). Fluorescence diagnosis can be achieved by 
measuring either autofluorescence, generated by endogenous molecules, or tissue 
fluorescence following administration of an exogenous agent.  
When fluorescence is observed in situ the resultant spectrum is superposition of several 
overlapping contributions of various fluorophores, which concentrations and special 
distribution vary depend on the stage of tissue pathology. It is typical to observe changes in 
intensity, or appearance/disappearance of fluorescent maxima with progression towards 
neoplasia. These spectral changes could indicate tissue pathological condition and stage of 
the lesion growth. 
In endoscopic fluorescence spectroscopy measurements we could distinguish two major 
directions, see fig. 1: 
1. Depending from the origin of the fluorescent signal detected – autofluorescence and 
exogenous (drug-enhanced) fluorescence; 
2. Depending from the signal detected – point measurements and two-dimensional 
images;  
Point measurements give us spectral data of the fluorescence, usually in terms of intensity of 
the fluorescence signal vs. wavelength, and two-dimensional images allow visualization of 
the mucosal area in terms of fluorescent color maps, which allow determination of 
boundaries and specification of the anatomic place of the pathology.  
Point spectral measurements are more sensitive and allow better differentiation between 
inflammatory and dysplastic areas vs. tumours, as the first ones could have significant 
similarities with the cancer sites, if observed in two-dimensional fluorescent images. This is 
related to diagnostic specificity evaluation using LIFS, as a diagnostic tool and there are 
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different ways to improve the values of LIFS sensitivity and specificity, using spectral 
analysis techniques, which are applied from different research groups to improve their 
fluorescent diagnostic observations. 
 
 
 
Fig. 1. Fluorescence detection techniques – principal scheme of 1-D and 2-D fluorescence 
imaging modalities 
In many research reports about spectral techniques’ feasibility foreseen to be introduced into 
clinical practice, both spectral modalities – autofluorescence and exogenous fluorescence are 
applied for better earlier diagnosis of gastrointestinal tumors. In the case of autofluorescence 
detection high sensitivity and specificity could be achieved, if complex algorithms are 
applied for differentiation of the spectra (Ell, 2003; DaCosta, 2006). However, detecting the 
difference in autofluorescence as a gastroendoscopic image still has been relatively difficult 
task because of spectra similarity and relative faintness of the signals. Recent real time 
gastrointestinal fluorescence endoscopy is all based on the use of exogenous fluorophores 
that increase the contrast, improve endoscopic resolution and sampling, and could be used 
to receive better 2-D visualization. 
2.1 Light-induced autofluorescence detection of gastrointestinal pathologies 
Autofluorescence is a term used to describe fluorescence emission from naturally occurring 
tissue molecules – endogenous fluorophores) such as aromatic amino acids, NADH, 
collagen and porphyrins. Each group of fluorophores is characterized by specific excitation 
and fluorescence emission wavelength ranges (see Table I), although it is common if use one 
excitation wavelength to excite several fluorophores and for their emission bandwidths to 
overlap, resulting in a broad and relatively featureless fluorescence spectrum. Major 
endogenous fluorophores, which produce autofluorescent spectrum observed from 
gastrointestinal mucosa are presented in Table 1, according data from investigations of 
independant research groups (Song, 2003; DaCosta, 2002; Wildi, 2003; Filip, 2011). 
Fluorescence diagnosis (FD) 
Autofluorescence 
(Endogenous fluorophores) 
e.g. aminoacids, proteins, NADH, 
flavins, porphyrins 
Exogenous fluorescence 
(Exogenous fluorophores) 
Exogenous PS: mTHPC, chlorins 
- Endogenous PS: 5-ALA/PpIX 
Imaging technique
e.g. Xillix LIFE-GI 
(Xillix Tech. Corp.)
Spectroscopy 
(point measurements 
= optical biopsy) 
Imaging technique 
e.g. D-light 
(Storz GmbH) 
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Fluorophore Origin 
Optimal excitation 
wavelength (nm) 
Peak of fluorescence 
emission (nm) 
Tryptophan amino acid 280, 305 340-350 
Tyrosine amino acid 275 300 
Phenylalanine amino acid 260 280 
Collagen structural protein 330-390 390-440 
Elastin structural protein 280, 360 350, 410 
Protein cross-links structural proteins 380-420 460-500 
Pyrodixine vitamin B6 compound 330-340 400 
Ceroid, lipofuscin 
lipo-pigment granules, 
oxidation products 
340-395 430-460, 540-640 
NADH metabolic co-factor 340 450-470 
FAD, Flavins metabolic co-factor 420-460 500-520 
Porphyrins 
heme biosynthesis 
byproducts;  
bacterial flora 
390-430, 630 635, 690 
Table 1. Excitation and emission wavelengths of various endogenous fluorophores in 
human tissues 
Different stages of tissue pathologies are associated with alterations in the content, special 
distribution and metabolic activities of these fluorophores, which affect the spectral shape of 
the autofluorescence signal. A number of different pathological processes – mainly 
neoplasia, but also inflammation and ischaemia affect the autofluorescence spectra observed 
from the tissue, due to their influence on metabolic, oxidative condition of the cells and their 
morphology. 
Tumour autofluorescence intensity is strongly reduced, due to several factors: (i) changes in 
the intercellular matrix due to tumour cells size increase vs. normal cells, that lead to 
reduction of collagen and elastin concentration on volume unit and decrease of the 
autofluorescent signal detected from given mucosal area; (ii) metabolic change of NADH, to 
its oxidized form NAD+ in tumour cells, which is non-fluorescent molecule; (iii) thickening 
of the mucosa, which screens off the blue-green autofluorescence from the collagen and 
elastin from submucosa layer; (iv) increase of concentration of optical absorbers in the 
tumour area, such as hemoglobin, due to the neo-vascularization in the tumours, which 
absorb in blue-green spectral region with maxima of absorption at 420-450 nm, peaks at 543 
and 575 nm-for oxy-hemoglobin and one broad peak at 550-580 nm for reduced hemoglobin 
form. 
Spectral shape of the autofluorescent signal is also affected, when neoplasia occur in the 
gastrointestinal tract. Usually when UV – blue light is used for excitation tumour areas 
fluorescence is shifted in red, resulting of endogenous porphyrins concentration raise, 
observed in these tissues, and normal mucosa fluoresce in blue-green spectral region. Many 
authors use the intensity ratios blue/red, green/red or vice-versa to develop diagnostic 
algorithms for evaluation of neoplastic changes in the tissues under investigation (Marcon, 
1999; Mayinger, 2001; DaCosta, 2002; Wildi, 2003; Mayinger, 2003; Song, 2003; Kara, 2005, 
Borisova, 2008; Aihara, 2009). This green/red ratio is used as a basis of XIllix Laser-Induced 
Fluorescence Endoscopy Gastrointestinal (LIFE-GI) (Xillix Technologies Corp., Canada) 
autofluorescence endoscope as a technique for detection of cancerous changes. This system 
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originally used blue light excitation and detected both green and red tissue 
autofluorescence, applying band-pass filters before two image intensifier cameras for 
observation of native fluorescence in the green and red spectral ranges, which are fused to 
create a real time “red-green” image of the pathology (DaCosta, 2006). Generally, there is 
less green fluorescence in neoplastic tissue, than in normal one, while red fluorescence is 
stronger in tumour than in normal tissue. These two systems LIFE-GI and newer LIFE II still 
use fiber endoscopes and not video-endoscopes (Ell, 2003). 
Special attention deserves the influence of hemoglobin absorption on the autofluorescence 
spectra obtained. Its increase is observed in tumor areas due to the vascular growth and the 
distortions in the autofluorescence tissue spectrum induced by this chromophore, which 
molecules absorb light without re-emission of own fluorescence. Hemoglobin is responsible 
for spectral dips at 420 nm and in the region of 540-580 nm. Depending from the 
oxygenation state of hemoglobin in green spectral region one could observe two minima – at 
543 and 575 nm, related to oxy-hemoglobin, or one broad minimum, in the region of 570-580 
nm– related to reduced form of this compound (Vladimirov, 2007; Borisova, 2008). As tumor 
lesions are hypoxic in their advanced stage – this could be used as additional indicator of 
the lesion severity and growth. However, hemoglobin absorption of the autofluorescence 
signal leads to distortion of the signal obtained. Such distortions could be mathematically 
simulated and extracted – to reveal intrinsic autofluorescence of the tissue, unaffected by 
absorption and scattering events. For better processing of the autofluorescence spectra 
received, researchers measured reflectance spectra from the same tissue area and extract 
signal, related to hemoglobin re-absorption of the native fluorescence of the tissue 
(Georgakoudi, 2001; Filip, 2011).  
In the case of autofluorescence detection high sensitivity and specificity could be achieved if 
complex algorithms are applied for differentiation of the spectra (Ell, 2003). However, on the 
current moment detecting the difference in autofluorescence as a gastroendoscopic image 
still has been relatively difficult task because of its faintness. The main advantage of the 
autofluorescence technique is the fact that it is not necessary to administrate chemical 
substance to the patient before fluorescence observations. Signal obtained is unstructured 
broad superposition of the fluorescent spectra of several intrinsic fluorophores, which do 
not allow easy recognition of the lesion type and need powerful mathematical algorithms 
for diagnostic differentiation of the normal/abnormal tissues. Significant disadvantages of 
exogenous fluorescent drugs usage are related to considerable medical and legal 
implications, as well as significant additional costs needed to obtain registration and 
approval for an exogenous fluorophore to be used as a medication. The advent of powerful 
light sources and highly sensitive detectors will lead to the development of autofluorescence 
endoscopy clinical systems. But on this moment real time gastrointestinal fluorescence 
endoscopy is based mainly on use of exogenous fluorophores. 
2.2 Light-induced exogenous fluorescence detection of gastrointestinal pathologies 
Tissue fluorescence could be enhanced following application of exogenous fluorescent drug, 
which is highly selective to cancerous and dysplastic tissues. Drug-mediated fluorescence is 
advantageous from the point of view of better visualization of the tumor area, with strong 
fluorescent signal, less ambiguous relative to autofluorescence and simpler and even 
cheaper instrumentation that could be used for exogenous fluorophores detection (Song, 
2003). Other advantage is related to the a priori knowledge about optical properties of 
exogenous fluorophore – its excitation and emission spectra are well known and its 
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applicability is related mainly to its selective localization within tissues of interest, mode of 
administration and low side effects to the patients. Of course, cost related to the process of 
registration and approval of such exogenous fluorophore is significant drawback for faster 
introduction of such fluorescence systems in clinical practice. 
Up to date, photosensitizers, used in photodynamic therapy, such as porphyrin derivative 
(HpD), delta-aminolevulinic acid (5-ALA), chlorines, have been exploited, and many of 
them fluoresce and demonstrate good selectivity for neoplasm. These drugs are also the 
most interesting for the investigators, as possible compounds applicable for exogenous 
fluorescence diagnosis of gastrointestinal tract.  
Most typical photosensitizers used for fluorescent detection of gastrointestinal neoplasia are 
presented in table 2. 
 
Photosensitizer 
Excitation
wavelength
 (nm) 
Fluorescence
 wavelength
peak (nm) 
Investigated pathologies 
5-ALA/ PpIX  
5-aminolevulinic 
acid/ proto-
porphyrin IX or 
hematoporphyrin 
derivative (HpD)
405, 514, 630 635, 690, 704 
Barrett esophagus, low- and high-grade 
colon dysplasia, esophageal squamous cell 
cancer adenocarcinoma, stomach carcinoma  
(Brand, 2002; Ortner, Messmann, 2003; Song, 
2005; Vladimirov, 2007; Ishizuka, 2011) 
chlorin (chlorin 
e6, mTHPC) 
660 665 
Esophageal squamous cell carcinoma 
(Gossner, 1998; Bourre, 2002) 
phthalocyanines 
(PCs) 
410, 530, 670 675-685, 740 
Stomach carcinoma, esophageal 
adenocarcinoma  
(Chissov, 2003) 
Table 2. Excitation and emission wavelengths of various exogenous photosensitizers and 
their gastrointestinal neoplasia diagnostic application. 
These compounds could be applied either for point spectroscopy or for imaging. 
Photosensitizers have high selectivity to neoplastic tissues and could accumulate 
significantly more in tumours. These compounds have strong fluorescence in red spectral 
region, 630-740 nm, where autofluorescence signal is very low, which allow better 
visualization and differentiation during video-endoscopic observations. 
In the most of the studies 5-ALA/PpIX is applied as fluorescent marker for tumor 
detection in esophagus and stomach. Less popular are fluorescent drugs, based on 
phthalocyanines and chlorines, applied for diagnosis as well as for therapeutic procedures 
based on photodynamic effect appearance in the tumor cells after light irradiation. Results 
achieved with 5-ALA/PpIX show very good correlation between fluorescence signals and 
histology examination of the lesions investigated. Rapid lesions border determination 
using exogenous fluorescence signal could be obtained in 1-D scanning spectroscopic 
mode. Our own results from in vivo detection show very good differentiation between 
normal and abnormal tissues in 1-D spectroscopic regime and moderate discrimination in 
2-D imaging using 5-ALA (Borisova, 2008b). Simple spectral discrimination algorithms 
allow to improve the differentiation between normal/cancerous mucosa, as well as to 
decrease the false positive results, related to the Protoporphyrin IX accumulation not only 
in tumor but in inflammatory cells of the esophagus and stomach. 
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For diagnostic purposes, delta-aminolevulinic acid is currently the compound that attracting 
greatest interest. 5-ALA is not a photosensitizer by itself, but a precursor in heme 
biosynthesis. In neoplastic cells activity of ferrochelatase, enzyme, attaching Fe2+ to the 
protoporphyrin IX, is strongly reduced, which lead to selective accumulation in malignant 
cells of this compound, which has photosensitizing properties, see figure 2. This effect could 
be observed using autofluorescence as well, but the concentration of PpIX in the tumour is 
much less than if 5-ALA is exogenously administered.  Preliminary studies suggest that 
protoporphyrin IX (PpIX) fluorescence resulting from exogenously administered 5-
aminolevulinic acid (5-ALA) may improve the detection of dysplastic mucosa in the GI tract 
(Brand, 2002). 5-ALA is a natural precursor of heme, which induces the formation of 
endogenous PpIX.  
The administration of exogenous ALA results in the accumulation of PpIX in tissue due to 
feedback inhibition of the final step of the heme biosynthetic cycle. Enzymatic differences in 
dysplastic tissue (e.g., decreased ferrochelatase activity) lead to an increase in PpIX 
concentration and following higher intensity red fluorescence.  
This mechanism of 5-ALA transformation to photosensitive PpIX is used not only for 
gastrointestinal tumor detection and photodynamic therapy, but as well for skin, bladder, 
bronchi, brain, lung cancer diagnosis and treatment. ALA-induced PpIX fluorescence has 
also been used successfully as a marker for dysplasia in many organs (Svanberg, 2004). 
Exogenous fluorescence detection of different mucosal neoplasia becomes a valuable tool for 
early detection and determination of malicious lesions during standard endoscopic 
observation. Real time fluorescent system, based on exogenous fluorescence detection of 5-
ALA/PpiX is developed by Storz company in Germany, so called D-Light system. Excitation 
lamp applied is filtered by short pass filter (<440 nm), and the blue light is delivered to the 
tissue investigated via illumination bundle of standard fibroscope. The fluorescent light is 
collected by endoscope imaging bundle and detected by video camera after second high-
pass filter (>450 nm), which reduced strongly the excitation light coming into the detector 
(Ell, 2003).   
 
  5-ALA      
Fig. 2. Structural formulas of the compounds delta-aminolevulinic acid and protoporphyrin 
IX and the time of transformation of 5-ALA to Pp IX 
Up to now only two gastroscopic systems- one based on autofluorescence - Xillix LIFE-GI 
and other based on exogenous 5-ALA/PpIX fluorescence - Storz D-Light with possibilities 
for fluorescence imaging detection are appeared on the market. In contrast, broad 
possibilities for choice of fluorescent bronchoscopes and cystoscopes exist, as the systems 
6-8 h, depending 
from the organ 
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are built in such way to allow fluorescent detection of tumors for example in bronchi or 
bladder. One of the technical problems, related to gastrointestinal applications are the 
losses of excitation and fluorescent signals through longer gastrointestinal endoscopes, 
which fade the images that could be observed. For detection of the fluorescence signal 
from gastrointestinal tract most of the researchers apply optical fibers through 
instrumental channel of the standard endoscopic equipment, which allow fluorescence 
detection of suspicious areas. We also applied such approach in our investigations; 
therefore we will present here only point spectral measurements. The 2-D pictures 
obtained from the common endoscopic video-equipment are relatively dim due to low 
level of the fluorescent light and in the improvement of the fluorescent video image is 
following step in our investigations. 
However, results achieved from point measurements already show very good correlation 
between fluorescence signals and histology examination of the lesions investigated. Rapid 
lesions border determination using exogenous fluorescence signal could be obtained. Other 
important issue in such investigations is the contrast between inflammatory and tumor 
areas, where one could observe very good differentiation, achieving of a contrast higher 
then three times in the intensity of the 5-ALA/PpIX fluorescence in the tumor area vs. 
inflammation (Borisova, 2008a). 
2.3 Advantages and drawbacks of fluorescence techniques for gastrointestinal 
tumours detection 
As mentioned above technological advances in fiber optics, light sources, detectors, and 
molecular biology have stimulated the development of numerous optical methods that 
promise to significantly improve our ability to visualize and evaluate human epithelium in 
vivo (Wang, 2004).  
The majority of gastrointestinal malignancies, especially adenocarcinoma, arise from 
epithelial surfaces. A common phenotype of all epithelial cancers is the progression from 
normal mucosa, through a stage of dysplasia, to cancer (Ell, 2003; Wildi, 2003; Song, 2003). 
The diagnosis of dysplasia based on standard endoscopy with multiple biopsies is still 
limited. S. M. Wildi and M. B. Wallace, 2003 discussed that in many cases dysplasia is 
invisible to the eye of the endoscopist, very common in flat lesions. Because of that is the 
need of numerous random biopsies and histological examination is the standard procedure. 
Although, such strategy could misses some dysplastic areas. Some visible lesions usually are 
not distinguished endoscopically from the surrounding nondysplastic tissue. On the other 
hand, the histological evaluation of biopsy specimens is difficult, especially differentiation 
between low grade and high grade dysplasia. There is significant inter-observer 
disagreement between pathologists in diagnosing dysplasia. 
Different methods such as chromoendoscopy, magnifying endoscopy, and optical-based 
spectroscopic and imaging modalities can increase the possibility to detect endoscopically 
precursor lesions and early stage of gastrointestinal cancer with combination of target 
biopsies (Ell, 2003; Ishizuka, 2011; Marcon, 1999; Song, 2003; Wildi, 2003; Wang, 2004,). They 
have the potential to overcome the limitations of standard endoscopic procedures by 
assessing wide neoplastic regions. These modalities may also provide a more accurate 
assessment of the extent of neoplastic lesions than conventional endoscopy, which is critical 
for success of the new endoscopic therapy, such as endoscopic mucosal resection (Wang, 
2004). Nevertheless, all of these new techniques are also associated with various limitations 
and standardization. 
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A great advantage of different autofluorescence techniques is that they can be implemented 
in vivo and give information about tissue in its native state. The detection of occult 
dysplastic or cancerous lesions is more accurate than standard endoscopy with biopsies 
(Wildi, 2003; Song, 2003). In addition, the results of C. Ell, 2003 showed that absence of 
dysplasia, early cancer, or inflammation was detected in fluorescence negative areas of 
Barrett’s mucosa, and consequently no false negative fluorescence findings were obtained. 
The data of L.-M. Wong Kee Song and B. C. Wilson, 2005 showed that targeted biopsies 
performed under LIFE endoscope in patients with short-segment Barrett esophagus 
identified more sites with high grade dysplasia than conventional biopsies obtained under 
standard endoscopy. On the opposite of these results, other study showed that both 
techniques had an equal sensitivity for high grade dysplasia and early cancer (Kobayashi, 
2001). Fluorescence spectroscopy is associated with low rate of sensitivity and specificity of 
‘low risk’ (non-dysplastic Barrett), and discriminating ‘high-risk’ (high grade dysplasia) 
from low grade dysplasia.  False-positives results occur in the presence of inflammatory or 
reactive changes (Ell, 2003). The reported diagnostic accuracy have depends on the sample 
size and wavelength(s) selection. One other advantage of the fluorescence spectroscopy is 
the easy passage of the probes through the accessory channel of standard diagnostic 
endoscopes and highly predictable geometry between fibers that provide the source of light 
and those that deliver collected light to the detector (Wildi, 2003). On the other hand, 
spectroscopic techniques are limited by the small surface area they examine at the tip of the 
probe compared to standard endoscopy (Song, 2003, 2005). In parallel with point 
spectroscopy, real-time fluorescence imaging prototypes, such as fiberoptic endoscopes or 
videoendoscopes, have been developed, providing a field of view, similar to that of a 
conventional endoscope. The application of drug-enhanced fluorescence imaging in the 
upper GI tract increase the sensitivity for detection of Barrett’s type dysplasia, but low 
specificity was found (Song, 2003). The fluorescence imaging with 5-ALA have similar 
limitations to autofluorescence imaging about a relative high number of false-positives 
results in cases with inflammation and metaplasia (Ell, 2003). In addition, the optimal dose 
of 5-ALA and whether topical application is capable of being as effective as oral 
administration is not estimated yet.  
So, the potential clinical use of fluorescent endoscopy is wide-area surveillance, as in Barrett’s 
esophagus and chronic inflammatory bowel diseases. T. Wang and J. Van Dam, J., 2004 
discussed that these methods of optical biopsy are unlikely to replace conventional biopsy 
with histopathological interpretation of excised tissue, but they are likely to provide a more 
accurate and efficient approach to target biopsy of diseased tissue, thus reducing the number 
of conventional biopsies required, increasing surveillance intervals, and reducing cost. L.-M 
Wong Kee Song and K. Wang, 2003, also discussed that optical-based techniques for diagnosis 
of premalignant lesions, as well as early gastrointestinal cancer remains “controversial”. 
Although they are promising modalities for detection of dysplastic or early neoplastic lesions. 
There is a need of technical optimization and confirmation of the preliminary results by future 
large number, prospective, randomized, controlled, cross-over clinical trials, as well as 
comparing the potential of drug-enhanced fluorescence detection relative to autofluorescence 
and to standard biopsy surveillance. The optimal technique may be a combination of optical 
modalities (multimodal optical diagnosis) with maximal diagnostic sensitivity and specificity. 
For instance, a lesion could be detected by a wide area surveillance technique such as 
autofluorescence imaging, and further characterized by a spectroscopic technique, such as 
exogenous fluorescence, Raman and/or confocal endoscopy.   
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C. Ell, 2003 discussed that fluorescent endoscopy may increase the detection of neoplastic 
lesions in the stomach but the clinical indications for fluorescence endoscopy is limited to 
patients with Barrett’s esophagus. Spectroscopic procedures still have higher sensitivity and 
specificity rates for identifying neoplastic lesions than imaging fluorescence systems. From 
the clinical point of view, only real time endoscopic fluorescence imaging systems represent 
a practicable solution. The systems that are currently available still have weaknesses, and 
will need to undergo thorough clinical evaluation once they have been technically 
optimized. In comparison with incoherent light sources, laser-based methods seem to be too 
elaborate and expensive, and the former are likely to replace them. In addition, fluorescence 
detection will have to be possible in the future using high resolution video endoscopes.  
According to the report of the American Society for Gastrointestinal Endoscopy (ASGE) 
Technology Committee, (Song, 2011), autofluorescence imaging, using probe-based 
spectroscopic devices and fiberoptic autofluorescence imaging (AFI) endoscopes have 
limited clinical value because of poor image quality related to fiberoptic technology. On the 
other hand video-endoscopic AFI systems is an improvement over earlier fiberoptic 
systems, but still have image quality inferior to high-resolution endoscopy. Improvements 
in image resolution, noise reduction, and color contrast may be achieved by further 
intensifying the autofluorescence signal and by optimizing the excitation and/or detection 
wavelength algorithms. In addition to steady-state fluorescence detection schemes, time-
resolved fluorescence imaging, which measures fluorescence decay as a function of time, 
may be a future method to help further enhance lesion detection. Quantitative analysis of 
AFI images and development of autofluorescence indices for tissue discrimination have the 
potential to improve diagnostic accuracy and complement, if not supplement, the visual 
interpretation of images. Ultimately, autofluorescence combined with the detection of a 
fluorescent contrast agent that has high affinity for a targeted tissue receptor (ie, molecular 
beacon) may be the optimal solution for fluorescence-based diagnosis. In addition to 
technological developments, randomized controlled trials are needed to assess the accuracy 
of AFI relative to high-definition white light imaging and other competing technologies, 
such as electronic mucosal enhancement techniques (eg, narrow-band imaging, multi band 
imaging). Inter-observer agreement and validation studies in non-enriched patient 
populations are also needed before AFI can be recommended for routine endoscopic 
practice. The report concluded that AFI may enhance lesion detection or differentiation in 
the GI tract, the technique currently lacks sufficient specificity to make it useful as a stand-
alone diagnostic modality during endoscopic practice. AFI may be a valuable tool when 
used as part of a multimodal imaging scheme, but this will require further technical 
advances and validation in prospective, randomized trials. 
3. Light-induced point fluorescence spectroscopy of gastrointestinal 
tumours 
Major spectral features observed during endoscopic investigations of gastrointestinal tumor, 
could be distinct as the next regions, according their origin and spectral region appearance, 
after application of 5-ALA and fluorescent excitation at 405 nm, as follow: 
1. 450-650 nm region, where tissue autofluorescence is observed;  
2. 630-710 nm region, where fluorescence of PpIX is clearly pronounced;  
3. 530-580 nm region, where minima in the autofluorescence signal are observed, related 
to re-absorption of oxy-hemoglobin in this spectral area.  
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Normal mucosa has bright autofluorescence, related mainly to the emission of co-enzymes, 
phospholipids, collagen, elastin, and protein cross-links. The intensity of autofluorescence in 
the case of neoplasia rapidly decrease, which could be used as additional indicator of 
pathology evaluation. 
 
  
        (a)                                                                         (b) 
Fig. 3. Fluorescence signal detected from normal esophagus (a) and stomach (b) walls and 
carcinoma, as typical example of the spectral features observed with exogenous photosensitizer 
delta-ALA/protoporphyrin IX and 405 nm excitation is applied (Borisova et al, 2008a). 
Normal esophagus and stomach autofluorescence lies in blue-green spectral area, which 
could be observed using video-endoscopy system such as D-Light (Filip, 2011) or 
autofluorescence endoscopic systems (Kara, 2005). 
3.1 LIFS of gastrointestinal tumours – experimental results 
Fluorescence intensity varies strongly from patient to patient; therefore most reasonable is 
the intra-patient comparison of the fluorescence intensity of normal tissue areas vs. 
suspicious ones. Even in the frames of one pathological area the intensity could vary, see fig. 
4 (Borisova, 2008c). One of the disadvantages discussed in the most of the papers is related 
to false-positive results, which could be obtained when inflammations appear in the 
esophageal or stomach walls. Inflammatory areas reveal red fluorescence, due to some 
selectivity of 5-ALA/PpIX in the inflammatory cells, where heme synthesis is delayed. 
Indeed, when video-observation is applied, it is not easy to differentiate the red signal 
coming from inflammatory area and from neoplastic lesion, but when point spectroscopy is 
applied, one could observe significant differences in the intensity levels of 5-ALA/PpIX 
fluorescence at 635 nm. Therefore, point spectroscopy allows to reach higher specificity of 
the diagnosis (Georgakoudi, 2001, Ortner, 2003), than video-endoscopic observation 
(Endlicher, 2001; Messmann, 2003).  
If compare relative intensities of normal and abnormal tissues sites for esophagus and 
stomach (see fig. 3b), the high level of the autofluorescence signal in the long wavelength 
spectral range (>600 nm) of the stomach wall, lead to problems in 2-D video-observation of 
the stomach tumor fluorescence. The values of the area of the autofluorescence spectrum of 
normal mucosa for the region >600 nm in comparison with the same region for tumor 
fluorescence are comparable and the ratio values between total areas of normal vs. tumor 
spectra in the region 600-800 nm vary from 0,7 to 1,1 for different patients.  
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Fig. 4. Fluorescence spectra obtained in vivo from different suspicious areas of an esophageal 
mucosa of one patient, after 6 h ALA/PpIX application, using 405 nm excitation – 
inflammatory mucosa and different points on tumor lesion (Borisova et al., 2008c). 
This effect could not be avoided by application of filter before CCD camera, as the long-pass 
filter (>600 nm) passed both signals – from normal mucosa autofluorescence and from 
exogenous 5-ALA/PpIX tumor fluorescence, see fig.5. 
 
 
Fig. 5. Comparison of the integrated fluorescence signal for the region 600-780 nm, calculated 
for all cases detected from stomach normal mucosa, inflammation, and carcinoma. Data are 
represented with the mean values of the areas calculated (Borisova et al., 2008b). 
As the human eye make an integration of the spectral signal when compare intensities, in  
2-D image the endoscopist will observe similar by color and light intensity areas, which also 
lead to specificity reduction, when video-endoscopic observation is applied (see table 3). 
These specificity values could reach 51% (Messmann, 2003) or even 27% (Endlicher, 2001), 
which makes them absolutely useless for 2-D diagnosis. If a long-wavelength filter is 
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applied to reject the autofluorescence from the normal mucosa sites red “tail” of the 
autofluorescence from the normal mucosa will be still detected and the contrast could not be 
improved. In that case only spectral data could increase the fluorescence detection 
sensitivity and specificity. 
This problem is still unsolved in the existing imaging systems for gastroscopic observations, 
but could be solved partially by change of excitation wavelength applied and this task is in a 
process of solving in our further investigations using longer wavelengths for excitation of 
PpIX (using peaks of absorption at 509 nm, 544 nm or 584 nm), where autofluorescence is 
not so strong factor, as well as back scattered excitation light from the mucosal surface does 
not lie in the spectral region of PpIX fluorescence itself. Drawback of this approach is the 
fact that fluorescence effectiveness is much less, when use excitation on these wavelengths, 
than at 405 nm, where the strongest absorption of PpIX is observed. 
When inflammatory areas occurred in the organ under investigation false-positive red 
fluorescence is observed in video channel of the endoscope due to the accumulation of PpIX 
in the both tumor and inflammatory areas. The contrast between the fluorescent signals at 
635 nm between tumor regions and inflammations observed in all patients, where such 
comparison was possible, usually is higher than two (Borisova, 2009). In such way one could 
be sure in general that using point fluorescence detection approach, he could distinguish 
inflammation from tumor site, and moreover, could distinguish inflammatory areas from 
normal mucosa. 
 
 
Fig. 6. Dimensionless ratio () R=I635/I560 calculated for all cases detected from normal 
mucosa, inflammation, dysplasia and tumor of stomach. Lines represent the mean values of 
this ratio calculated (Borisova et al., 2009). 
The fluorescent intensities of the maximum at 635 nm of inflammatory area detected from 
stomach wall are close to the lowest signals received from tumors. Therefore, an additional 
criterion could be applied for better differentiation of inflammation from tumor. We used 
for these goals a dimensionless ratio R=I635/I560, see fig.6. Using this simple algorithm very 
good differentiation tumor/inflammation is obtained that could be applied for clinical 
practice needs. Moreover, similar approaches are proposed for differentiation of normal and 
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cancerous sites from other research groups, for gastrointestinal tumors, cancer detection in 
bronchi and lungs. Using green and red band-pass filters two complimentary images are 
received and ratio between them is calculated to receive more contrast image and to 
improve sensitivity and specificity of the fluorescent endoscopy approach (Sokolov, 2002, 
2005; Goujon, 2001). 
3.2 LIFS of gastrointestinal tumours – sensitivity and specificity peculiarities 
When new diagnostic approach is introduced into the medical practice, major indicators of 
its clinical applicability are the values of sensitivity and specificity of such newly developed 
method. As we already mentioned, when discussed advantages and drawbacks of light-
induced fluorescence diagnostics – this technique, nevertheless if autofluorescence, or drug-
enhanced exogenous fluorescence detection is applied, is only complimentary on its recent 
level of development. In some next stage of its development, when more sensitive detectors, 
or more complicate mathematical algorithms for image analysis are applied in video-
endoscopes used for gastrointestinal tumor observations, this high sensitive method could 
found primary place as a diagnostic tool.  
Nowadays, all reports on exogenous fluorescence diagnostics related to evaluation of 
statistical diagnostic values show an excellent sensitivity of fluorescent diagnostic technique 
and moderate, even poor specificity values. We stopped our attention on few reasons for 
such low values of the specificity: 
i. false-positive red fluorescence, due to selectivity of exogenous photosensitizers, not 
only to tumor cells, but also to inflammatory areas; 
ii. significant autofluorescence signal in the spectral range above 600 nm, which lead to 
problems with differentiation during 2-D video observation of lesion fluorescent 
images; 
As we will see from the comparison of the results, obtained from other research groups (see 
table 3), other possible reasons for low specificity values of this technique, up to now are: 
iii. strong dependence on the fluorescent drug concentration to the contrast tumor/normal 
mucosa observed; 
iv. drug application influence on the selective accumulation of the fluorophore into tumor 
area – intravenous, using spray catheter, enema, orally, etc. 
In table 3 are presented data from investigations, which allow observing the general 
tendencies and influences on the sensitivity and specificity values obtained, depending from 
the initial conditions applied. 
Messmann and group, 2003,  applied 5-ALA using three different ways – orally, using spray 
catheter and enema for detection of low-grade and high-grade colon dysplasia. Endoscopic 
observations were performed using fibrescopes, connected to a light source delivering 
white, or blue light (D-light, Storz, Germany) and the evaluations of SE and SP were based 
on the observed real time fluorescence pictures. According observations, optimal way of 
application is using spray catheter, as there sensitivity is 100%, and moderate but relatively 
higher value of specificity is reached – 62 %. Authors called the fluorescent technique 
“promising” for detection of LGD and HGD in ulcerative colitis, but observed high rate of 
false-positive fluorescent signals related to inflammatory areas. Unequal absorption of 5-
ALA using enema or spray catheter also need to be taken into account and cannot be 
excluded as possible source of methodological errors. Authors stress on the fact that they 
received high percentages for the negative predictive values, which allow concluding an 
indication that there is almost no colon dysplasia in a negative fluorescence observations.  
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Lesion site/type Method 
Excitation 
[nm] 
Emission 
[nm] 
SE 
[%] 
SP 
[%] 
Reference 
Exogenous fluorescence  
Barrett esophagus – 
low grade dysplasia 
(LGD) 
5-ALA - PpIX 505 nm 
635 nm, 
699 nm 
100 67 Ortner, 2003 
LGD and high-grade 
dysplasia (HGD) - 
colon 
5-ALA –enema, 
3g 
390-405 nm 
– D-light 
2-D images
635-700 nm
87 51 
Messmann, 
2003 
LGD and HGD - colon
5-ALA –spray 
catheter, 3g 
390-405 nm 
– D-light 
2-D images
635-700 nm
100 62 
Messmann, 
2003 
LGD and HGD - colon
5-ALA – orally,
20 mg/kg 
390-405 nm 
– D-light 
2-D images
635-700 nm
43 73 
Messmann, 
2003 
Barrett esophagus 
5-ALA – orally 
10 mg/kg 
390-405 nm 
– D-light 
2-D images
635-700 nm
80 56 
Endlicher, 
2001 
Barrett esophagus 
5-ALA – orally 
20 mg/kg 
390-405 nm 
– D-light 
2-D images
635-700 nm
100 51 
Endlicher, 
2001 
Barrett esophagus 
5-ALA – orally 
30 mg/kg 
390-405 nm 
– D-light 
2-D images
635-700 nm
100 27 
Endlicher, 
2001 
Esophageal 
adenocarcinoma 
5-ALA – orally 
15 mg/kg 
<450 nm >600 nm 85 53 
Mayinger, 
2000 
Endogenous fluorescence (autofluorescence)  
High-grade dysplasia 
vs. LGD and 
nondysplastic tissue 
LIAFS 
337nm 
397 nm 
400-420 nm
440-480 nm
100 97 
Georgakoudi, 
2001 
LGD and HGD vs. ND 
Barrett 
LIAFS 
337nm 
397 nm 
400-420 nm
440-480 nm
79 88 
Georgakoudi, 
2001 
Barrett esophagus 
Autofluorescence 
LIFE-GI system 
N/A 500-550 nm 97 97 Ell, 2003 
Rectal cancer Autofluorescence 375-478 nm 500-700 nm 96 93 
Mayinger, 
2003 
Stomach 
adenocarcinoma 
Autofluorescence 375-478 nm 500-700 nm 90 95 
Mayinger, 
2001 
Gastric carcinoma Autofluorescence
437 nm 
LIFE-GI 
system 
490-700 nm 94 86 
Kobayashi, 
2001 
Table 3. Sensitivity and specificity received using LIFS of gastrointestinal tract for different 
localisations using autofluorescent or exogenous fluorescent detection of lesions 
Interesting investigation, related to the optimisation of exogenous fluorophore 
concentration is carried out by Endlicher and group (Endlicher, 2001) for detection of low-
grade and high-grade dysplasia in Barrett esophagus. Again, the observations are made in 
2-D regime, not as point spectral measurements, which explain partially the moderate 
values of specificity received, 4-6 hours after oral application of 5-ALA to the patients. The 
lower and upper limits of 5-ALA concentrations applied reveal that number of fluorescent 
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negative biopsies in the patients’ group sensitized with 30 mg/kg was extremely low, due to 
the high background fluorescence. In contrary, when 5 mg/kg 5-ALA is applied to the 
patients, only weak fluorescence appear and therefore the number of positive biopsies is 
lower in that group. Additionally false positive fluorescence was induced mainly by 
inflammatory areas and metaplasia, as well as from reflux of bile into the esophagus, which 
was associated with intensive red fluorescence. Optimal values for 5-ALA oral applications 
are received for 15-20 mg/kg dose. Researchers also observed that while local sensitization 
caused no side effects, systemic application of 5-ALA with doses higher than 20 mg/kg 
could cause mild nausea or vomiting in a few of the patients, as well as transient increases in 
liver enzymes in two patients from 58 examined persons. Skin photosensitivity using 5-ALA 
is relatively low and disappears after several hours after systemic administration, but 
disappear totally after 18 hours for all patients. 
In the second part of the table 3 are presented results from investigations using 
autofluorescence as a diagnostic tool. When autofluorescence detection is applied high 
values for sensitivity and specificity (higher than 90 %) are reported from all research 
groups. Autofluorescence spectroscopy is characterized with high values for both these 
diagnostic parameters. The biggest problem of this technique is the visualization of the 
pathologies, useful for the clinicians, which still waits for its technical solution. Point 
spectral data detected are useful and informative for the physicists and engineers, who work 
on the development of this technique for its introduction into the clinical practice. But these 
data are not so exciting for the clinicians, who prefer to visualize their objects of interest, 
developing 2-D images, based on real or pseudo-color maps, based on the optical properties 
of the investigated tissues. Xillix LIFE-GI system is one possible answer of such need, but 
still not optimized for daily clinical observations.  
4. Conclusions 
Theoretically spectral diagnosis can provide imaging and point spectroscopic information in 
both - morphological and biochemical data modes with extreme sensitivity and specificity. 
Advances in spectroscopic instruments will improve imaging’s role as a facilitator of 
research translation. Results received in the recent studies could serve for development of 
tools for quantifying in vivo tumor growth and origin and for accelerating the transition 
from pre-clinical studies to early clinical trials and to routine diagnostic practice. Beyond all 
doubts, application of new, more sensitive tool for diagnostics of esophageal and stomach 
neoplasia could potentially make fluorescence surveillance clinically and cost effective 
procedure. 
Despite of the fluorescent endoscopic systems developed and already discussed under 
clinical and laboratorial investigations, the fluorescent diagnosis of tumors of the 
gastrointestinal tract is still very challenging and extensive research and development task 
worldwide. With the optimization of the procedures and evaluation of diagnostic added 
value of the technique, through development of appropriate algorithms based on 
fluorescence properties of the investigated sites, a novel high sensitive diagnostic tool could 
be successfully applied as complementary to the standard white light endoscopy.  
But on this moment real time gastrointestinal fluorescence video-endoscopy rely on the use 
of exogenous fluorophores and contrast, which would be observed after exogenous 
fluorophore application. Most popular precursor of a photosensitizer is delta-aminolevulinic 
acid/Protoporphyrin IX (5-ALA/PpIX) that is also used as fluorescent marker for dysplasia 
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and tumor detection in many other anatomical sites. 5-ALA/PpIX has low toxicity, very 
good selectivity to the tumor tissues and reveals high contrast normal/abnormal tissue, 
which makes it preferable form of exogenous fluorophore for clinical applications.  
Results achieved with 5-ALA/PpIX show very good correlation between fluorescence 
signals and histology examination of the lesions investigated. The lack of fluorescence peaks 
in the red spectral area for normal mucosa is an indication for selective accumulation of 5-
ALA/PpIX only in abnormal sites and gives high contrast when lesion borders are 
determined from clinicians during video observation in the process of diagnostic procedure. 
Rapid lesions border determination using exogenous fluorescence signal is obtained in such 
way. However, more detailed investigation about differences in the accumulation of 5-
aminolevulinic acid/protoporphyrin IX in neoplastic and inflammatory areas will be useful 
to evaluate and optimize the contrast between these tissue conditions.  
In conclusion, optical spectroscopic and imaging modalities, such as fluorescence 
endoscopy, narrow band imaging, optical coherence tomography, and confocal endoscopy, 
are still under evaluation and should be considered research tools at the current time. 
Although promising, instrument optimization, diagnostic reproducibility, and validation 
through large-scale prospective comparative trials are needed before optical spectroscopic 
and imaging techniques are considered part of routine endoscopic practice. Ultimately, 
whether and to what extent fluorescence endoscopy will find its place in clinical 
gastroenterology will only be decided in comparison with the other imaging options 
available (high resolution endoscopy, magnification endoscopy, chromo-endoscopy, etc). 
Additionally the cost effectiveness of spectroscopic screening needs to be further assessed in 
prospective studies. 
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